Panel to decide on AstraZeneca Covid vax trials after unexplained illness in UK

Panel to decide on AstraZeneca Covid vax trials after unexplained illness in UK

Mid-Day

Published

Pharma major AstraZeneca has said it is working to expedite the review of the single event to minimise any potential impact on the trial timeline of its Covid-19 vaccine candidate.

AstraZeneca said in a statement that as part of the ongoing randomised, controlled clinical trials of the AstraZeneca Oxford coronavirus vaccine,...

Full Article